Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
New commercial paper securities of Kotak Mahindra Prime Limited listed on BSE Debt segment with face value of Rs. 5 lakh each, maturing on … | |||||||||||||||
New commercial paper securities of Kotak Mahindra Prime Limited listed on BSE Debt segment with face value of Rs. 5 lakh each, maturing on November 24, 2026.
| |||||||||||||||
BSE announces listing of 3,500 Commercial Papers of Rs. 5 lakh each issued by Network 18 Media & Investments Limited on private placement … | |||||||||||||||
BSE announces listing of 3,500 Commercial Papers of Rs. 5 lakh each issued by Network 18 Media & Investments Limited on private placement basis, effective December 12, 2025.
| |||||||||||||||
BSE lists commercial paper worth Rs. 500 crores issued by Pilani Investment and Industries Corporation Limited on private placement basis, … | |||||||||||||||
BSE lists commercial paper worth Rs. 500 crores issued by Pilani Investment and Industries Corporation Limited on private placement basis, maturing on March 13, 2026.
| |||||||||||||||
BSE announces listing of new Commercial Paper worth Rs. 500 crores issued by Pilani Investment and Industries Corporation Limited on private … | |||||||||||||||
BSE announces listing of new Commercial Paper worth Rs. 500 crores issued by Pilani Investment and Industries Corporation Limited on private placement basis.
| |||||||||||||||
New commercial paper of Rs. 5 lakh denomination listed on BSE Debt segment with ICRA A1+ rating, maturing on December 11, 2026. | |||||||||||||||
New commercial paper of Rs. 5 lakh denomination listed on BSE Debt segment with ICRA A1+ rating, maturing on December 11, 2026.
| |||||||||||||||
Shareholding pattern disclosure for Corona Remedies Limited post-IPO listing showing promoter holding of 68.9959% and public holding of … | |||||||||||||||
Shareholding pattern disclosure for Corona Remedies Limited post-IPO listing showing promoter holding of 68.9959% and public holding of 31.0041%.
| |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol … | |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol CORONA.
| |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol … | |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol CORONA.
| |||||||||||||||
Shareholding pattern filing under Reg. 31(1)(a) for Corona Remedies Limited post-issue as of December 12, 2025, showing promoter holding at … | |||||||||||||||
Shareholding pattern filing under Reg. 31(1)(a) for Corona Remedies Limited post-issue as of December 12, 2025, showing promoter holding at 68.9959% and public holding at 31.0041%.
| |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol … | |||||||||||||||
BSE announces the upcoming listing and admission to trading of equity shares of Corona Remedies Limited with scrip code 544644 and symbol CORONA.
| |||||||||||||||